On October 26, 2025, Genenta Science S.p.A. announced a registered direct offering of 4,285,715 American Depositary Shares at $3.50 each, aiming to raise approximately $15 million for general corporate purposes. The offering is expected to close on October 28, 2025, with a lock-up period for company insiders.